x

Hledat klinickou studii

* (*) povinné pole

16 Výsledků

Studie přijímající pacienty = Studie přijímající pacienty
; Probíhající studie = Probíhající studie; Ukončená studie = Ukončená studie; Financováno členem konsorcia IRDiRC = ; Člen ERN =

Národní klinické studie

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTRestoring Dystrophin Expression in Duchenne Muscular Dystrophy: A Phase I/II Clinical Trial Using AVI-4658 (morpholino oligomer directed against exon 51)
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTAn open-label, multi-center controlled clinical trial of eculizumab in adult patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK -
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTAn open-label, multi-center controlled clinical trial of eculizumab in adolescent patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK -
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTAn open-label, multi-center controlled clinical trial of eculizumab in adult patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTAn open-label, multi-center controlled clinical trial of eculizumab in adolescent patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

Financováno členem konsorcia IRDiRCMISSING CONTENTA Phase III Efficacy and Safety Study of Ataluren (PTC124) in Patients with Nonsense Mutation Dystrophinopathy - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTAn open-label extension study of the long-term safety, tolerability and efficacy of GSK2402968 in subjects with Duchenne Muscular Dystrophy (phase III) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTFOR-DMD: Duchenne muscular dystrophy: doubleblind randomized trial to find optimum steroid regimen (phase III) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

Financováno členem konsorcia IRDiRCMISSING CONTENTAn Open-Label Study for Previously Treated Ataluren (PTC124®) Patients with Nonsense Mutation Dystrophinopathy (phase III) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

Financováno členem konsorcia IRDiRCMISSING CONTENTPTC124-GD-007-DMD: A Phase 2b Efficacy and Safety Study of PTC124 in Subjects with Nonsense-Mutation-Mediated Duchenne and Becker Muscular Dystrophy - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTPhase II Feasibility Study of the Efficacy and Acceptability of a Low Residue Diet in Adult Patients With Mitochondrial Disease
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SPOJENÉ KRÁLOVSTVÍ

Tyne & Wear
NEWCASTLE UPON TYNE